Montemurro F |
Trastuzumab emtansine in HER2-positive metastatic breast cancer. |
2017 |
Lancet Oncol. |
pmid:28526537
|
Li C et al. |
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function. |
2017 |
Clin Pharmacokinet |
pmid:27995530
|
Kmietowicz Z |
NICE approves trastuzumab emtansine after deal with drug company. |
2017 |
BMJ |
pmid:28623237
|
Krop IE et al. |
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial. |
2017 |
Lancet Oncol. |
pmid:28526538
|
Diéras V et al. |
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. |
2017 |
Lancet Oncol. |
pmid:28526536
|
Morimura O et al. |
Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models. |
2017 |
Biochem. Biophys. Res. Commun. |
pmid:28526406
|
Li Y et al. |
EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer. |
2017 |
Int J Nanomedicine |
pmid:28894364
|
Chen SC et al. |
Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2-targeted regimens. |
2017 |
Br J Clin Pharmacol |
pmid:28733983
|
Iwamoto N et al. |
LC-MS bioanalysis of Trastuzumab and released emtansine using nano-surface and molecular-orientation limited (nSMOL) proteolysis and liquid-liquid partition in plasma of Trastuzumab emtansine-treated breast cancer patients. |
2017 |
J Pharm Biomed Anal |
pmid:28648785
|
Seidel K et al. |
Synthesis of Magnetic-Nanoparticle/Ansamitocin Conjugates-Inductive Heating Leads to Decreased Cell Proliferation In Vitro and Attenuation Of Tumour Growth In Vivo. |
2017 |
Chemistry |
pmid:28585348
|